Elevated serum plasminogen activator inhibitor-1 is associated with seizure burden, drug resistance, and neuroinflammatory markers in pediatric epilepsy

• by Xiao Xiao, Xiaoyan Shi, Jun Feng, Xinyu Zhou, Manli Wang, Bingbing Zhang, Chen Xu, Jihong Tang

• July 14, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

Baptist Health Brain & Spine Care to Host 14th Annual Miami Neuroscience Symposium Nov. 4-6, Bringing Leading Experts Together to Explore Advances in Brain and Spine Care

Baptist Health will bring together leading physicians, researchers and healthcare professionals from South Florida and across the country for the 14th Annual Baptist Health Miami Neuroscience Symposium, taking place Nov. 4-6, 2026, at Hilton Miami Dadeland and virtually via Zoom.

• by

• August 21, 2026

• 5 min

Sedative medications: a potentially modifiable risk factor for improving neurocognitive outcomes after critical illness in infants and children

• by Alana GaHyun Byeon, Marina Mir, Angela Jerath, Marat Slessarev, Saptharishi Lalgudi Ganesan, Nicole K. McKinnon

• July 20, 2026